Here is a look at some interesting infectious disease and health news, opinion and research reported across the globe: New Tuberculosis Drug May Shorten Treatment Time for Patients A new experimental...

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir)to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with...

The Canadian Task Force on Preventive Health Care recommends against screening for chronic hepatitis C virus (HCV) in adults at low risk in a guideline published in CMAJ (Canadian Medical Association Journal). “Given...

The Iowa Department of Public Health (IDPH) has released its first report on hepatitis C infection in Iowa. Hepatitis C is the leading cause of liver cancer and liver transplants in the U.S. A comparison...

First regimen to treat all six major HCV genotypes The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced...

The U.S. Food and Drug Administration today approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated...

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV)...